NewsEvents

Your Yourlocation: Home > Combination of tiotropium bromide(136310-93-5) and salmeterol in the treatment of chronic obstructive pulmonary disease

Heilongjiang Province Yingchun Forestry District People's Hospital Deng Jianying and others studied of tiotropium bromide(136310-93-5) combined with salmeterol treatment of chronic obstructive pulmonary disease in patients with stable phase observation, the study found that tiotropium bromide(136310-93-5) combined with salmeterol treatment of stable COPD clinical effect is significant, can effectively improve the patient's lung function, it is worth promoting. The article published on 2016 03 "Northern Pharmacy".

The aim of this study was to investigate the clinical efficacy of tiotropium bromide(136310-93-5) combined with salmeterol in the treatment of stable chronic obstructive pulmonary disease (COPD).

The investigators randomized 78 stable COPD patients in our hospital into two groups, 39 patients in each group. The control group was treated with tiotropium and the observation group was treated with salmeterol in the control group. The clinical effects of the two groups were compared.

The results showed that the 6-min walking distance, FEV1, FEV1%, FVC, IC and dyspnea scores of the observation group were significantly better than those of the control group (P <0.05).

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved